Overview
- 15 inspections across 15 sites are on record.
- 40 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-28.
At a glance
Inspections
15
Sites
15
Observations
40
Career since
Nov 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Linde Inc. | 28 May 2026 | Human Drugs | |
| Pharmaceutical Manufacturing Research Services, Inc | 1 May 2026 | Human Drugs | |
| Carecam International, Inc. | 23 Oct 2025 | Human Drugs | View 483 → |
| PAI Holdings, LLC | 22 Aug 2025 | Human Drugs | |
| SV Labs Prescott Corporation | 13 Jun 2025 | Human Drugs | View 483 → |
Sites inspected
Linde Inc.Baltimore, United States1 insp.
Pharmaceutical Manufacturing Research Services, IncHorsham, United States1 insp.
Carecam International, Inc.Fairfield, United States1 insp.
PAI Holdings, LLCBridgewater, United States1 insp.
SV Labs Prescott CorporationPrescott, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Pushpa S Jayasekara4 shared
Jessica S Estriplet3 shared
Catherine O Lamptey3 shared
Michael O Idowu2 shared
Vivin George2 shared
Mindy M Chou1 shared
Paranthaman SenthamaraiKannan1 shared
Syeda N Mahazabin1 shared
Johnny D Nwankwo1 shared
Yaharn Su1 shared
Full investigator report
Get the verbatim findings behind Olumide A Akinyemi's 40 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site